Loading stock data…
Nuwellis, Inc. (NUWE)
$0.79+0.01 (+0.88%)
Market ClosedLast close Sep 8
Nuwellis, Inc., a medical device company, develops, manufactures, and commercializes medical devices used in ultrafiltration therapy.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
Nuwellis, Inc. in the Healthcare sector is trading at $0.79 with a market capitalization of $1M. The stock is currently near its 52-week low of $0.71, remaining 98.1% below its 200-day moving average. On fundamentals, Piotroski 3/9 flags weak fundamentals, Altman Z in the distress zone. Risk note: RSI 21 is oversold, raising the odds of a near-term bounce. The Whystock Score of 25/100 signals elevated caution as multiple indicators diverge.
Ecosystem Influences
Long-term trend bearish (price vs 200-day SMA)
Oversold momentum (RSI 21) — potential for technical mean-reversion
Macro-economic sensitivity to interest rate and inflation shifts
Quarterly Financials
| Metric (USD) | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Total Revenue | $2.40M↓ | $2.42M↑ | $2.22M↑ | $1.73M↓ | $1.90M |
| Gross Profit | $1.68M↑ | $1.65M↑ | $1.45M↑ | $958,000↓ | $1.07M |
| Operating Income | -$4.57M↓ | -$2.44M↑ | -$2.70M↑ | -$2.91M↑ | -$3.06M |
| Net Income | -$4.54M↓ | -$2.42M↓ | $468,000↑ | -$12.55M↓ | -$3.01M |
Peer Comparison
JNJUNHPFE
Fundamentals
Nuwellis, Inc., a medical device company, develops, manufactures, and commercializes medical devices used in ultrafiltration therapy. The company provides Aquadex FlexFlow and Aquadex SmartFlow systems, which are used to treat patients suffering from...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$1.30M
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
High-beta play. Expect amplified moves vs. the broad market.
-
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
-713.68%
Volume
Today's trading volume
293,517
Recent News
Nuwellis Inc (NUWE) (Q2 2026) Earnings Call Highlights: Revenue Surges 14% and Installed Base ...
Nuwellis Inc (NUWE) reports strong U.S. growth and improved gross margins while advancing its pediatric label expansion and strategic cardiorenal platform initiatives.
Nuwellis’ new CEO on building a strong foundation for sustainable value creation
Mike McCormick became Nuwellis' new CEO on 30 June and aims to build on the company's positive Q1 2026 performance.
Nuwellis Shares Sink After Pricing $6 Million Equity and Warrant Offering (NUWE)
Nuwellis Inc. (NASDAQ:NUWE) shares plunged 65.
Nuwellis Inc (NUWE) Q1 2026 Earnings Call Highlights: Strong Revenue Growth and Strategic ...
Nuwellis Inc (NUWE) reports a 26% revenue increase and strategic acquisition, but faces liquidity constraints and rising operating expenses.
Nuwellis, Inc. Q1 2026 Earnings Call Summary
Moby summary of Nuwellis, Inc.'s Q1 2026 earnings call